Stephen R. Davis
2020
Compensation breakdown
| Non-Equity Incentive Plan | $438,601 |
|---|---|
| Option Awards | $3,273,559 |
| Salary | $767,624 |
| Stock Awards | $3,262,978 |
| Other | $20,425 |
| Total | $7,763,187 |
Davis received $3.3M in option awards, accounting for 42% of the total pay in 2020.
Davis also received $438.6K in non-equity incentive plan, $767.6K in salary, $3.3M in stock awards and $20.4K in other compensation.
Rankings
In 2020, Stephen R. Davis' compensation ranked 1,208th out of 13,090 executives tracked by ExecPay. In other words, Davis earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,208 out of 13,090 | 91st |
Division Manufacturing | 429 out of 5,621 | 92nd |
Major group Chemicals And Allied Products | 149 out of 2,254 | 93rd |
Industry group Drugs | 129 out of 1,954 | 93rd |
Industry Pharmaceutical Preparations | 95 out of 1,459 | 94th |
Pay ratio
| Stephen R. Davis' Pay | $7,763,187 |
|---|---|
| Median Employee's Pay | $218,247 |
| Pay Ratio | 36to 1 |
In 2020, the annual total compensation of Stephen R. Davis was $7,763,187.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $218,247.
The ratio of Stephen R. Davis' pay to the pay of median employee was therefore 36 to one.
Davis' colleagues
We found four more compensation records of executives who worked with Stephen R. Davis at ACADIA Pharmaceuticals in 2020.